Data dictionary: Melanoom - DMTR: Difference between revisions

From Beacon
(Created page with "Go back to Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands) page. This is a summary of the variables available in the database. You can download the complete data dictionary. [https://dica.nl/data-aanvragen/ Click here to learn more]. '''Basic Patient Information''' * Healthcare Facility * Unique Patient Number * Date of Birth * Gender * Date of Death (if applicable) '''Melanoma Center Details''' * Hospital Patient Number * Date of First D...")
 
No edit summary
Line 3: Line 3:
This is a summary of the variables available in the database. You can download the complete data dictionary. [https://dica.nl/data-aanvragen/ Click here to learn more].
This is a summary of the variables available in the database. You can download the complete data dictionary. [https://dica.nl/data-aanvragen/ Click here to learn more].


'''Basic Patient Information'''
'''Table 1:''' Basic Patient Information.
* Healthcare Facility
{| class="wikitable"
* Unique Patient Number
! Variables
* Date of Birth
|-
* Gender
| Healthcare Facility
* Date of Death (if applicable)
|-
| Unique Patient Number
|-
| Date of Birth
|-
| Gender
|-
| Date of Death (if applicable)
|}


'''Table 2:''' Melanoma Center Details.
{| class="wikitable"
! Variables
|-
| Hospital Patient Number
|-
| Date of First Disease Presentation Diagnosis of Melanoma
|-
| Patient Type
|-
| Location of Primary Tumor
|-
| Pathology (PA) Result Known?
|-
| PA Number (TJJ-CCCCCC)
|-
| PA Laboratory
|}


'''Melanoma Center Details'''
'''Table 3:''' Tumor Characteristics and Diagnosis.
* Hospital Patient Number
{| class="wikitable"
* Date of First Disease Presentation Diagnosis of Melanoma
! Variables
* Patient Type
|-
* Location of Primary Tumor
| Type of Eye Melanoma
* Pathology (PA) Result Known?
|-
* PA Number (TJJ-CCCCCC)
| Type of Melanoma
* PA Laboratory
|-
| Breslow Thickness in Millimeters (unknown = 999)
|-
| Ulceration
|-
| Satellite / In-transit Metastasis
|-
| Sentinel Node Procedure Performed at Primary Diagnosis?
|-
| Capsule Rupture Occurrence?
|-
| Sentinel Node Diameter
|-
| Primary Melanoma Regression?
|-
| Lymph Node Metastases (macroscopic)
|-
| Distant Metastases
|-
| Locations of Current Tumor Presentation
|}


'''Table 4:''' Comorbidities.
{| class="wikitable"
! Variables
|-
| Cardiac
|-
| Vascular
|-
| Diabetes
|-
| Pulmonary
|-
| Neurological/Psychiatric
|-
| Gastrointestinal
|-
| Urogenital
|-
| Thrombotic
|-
| Musculoskeletal
|-
| Endocrine Disorders
|-
| Infectious Diseases
|-
| Malignancy
|-
| Autoimmune Disorders
|-
| Organ Transplantation
|-
| Other Comorbidities
|}


'''Tumor Characteristics and Diagnosis'''
'''Table 5:''' Medications Usage.
* Type of Eye Melanoma
{| class="wikitable"
* Type of Melanoma
! Variables
* Breslow Thickness in Millimeters (unknown = 999)
|-
* Ulceration
| Analgesics: Start and Stop Dates, Reason for Use
* Satellite / In-transit Metastasis
|-
* Sentinel Node Procedure Performed at Primary Diagnosis?
| Antibiotics: Start and Stop Dates, Reason for Use
* Capsule Rupture Occurrence?
|-
* Sentinel Node Diameter
| Antiviral Agents: Start and Stop Dates, Reason for Use
* Primary Melanoma Regression?
|-
* Lymph Node Metastases (macroscopic)
| Anticoagulants and Thrombolytics: Start and Stop Dates, Reason for Use
* Distant Metastases
|-
* Locations of Current Tumor Presentation
| Anticonvulsants: Start and Stop Dates, Reason for Use
|-
| Antiemetics: Start and Stop Dates, Reason for Use
|-
| Anti-inflammatory Drugs: Start and Stop Dates, Reason for Use
|-
| Corticosteroids: Start and Stop Dates, Reason for Use
|-
| Imuran (Azathioprine): Start and Stop Dates, Reason for Use
|-
| Interferon: Start and Stop Dates, Reason for Use
|}


'''Table 6:''' Metastases and Staging.
{| class="wikitable"
! Variables
|-
| Metastases Staging?
|-
| Tumor Stage Before (Neo)adjuvant Treatment
|-
| Imaging: CT Thorax and/or Abdomen, PET-CT, MRI or CT of the Brain
|-
| Lab Tests: S100, LDH Levels
|-
| Locations of Current Tumor Presentation Metastases Confirmed?
|-
| In-transit Metastases and/or Satellitosis
|-
| Recurrent Primary Melanoma
|}


'''Comorbidities'''
'''Table 7:''' Histology and Genetics.
* Cardiac
{| class="wikitable"
* Vascular
! Variables
* Diabetes
|-
* Pulmonary
| Histology of Primary Tumor Examined
* Neurological/Psychiatric
|-
* Gastrointestinal
| Revision Histology of Primary Tumor
* Urogenital
|-
* Thrombotic
| Histology and/or Cytology of Current Tumor Presentation Available
* Musculoskeletal
|-
* Endocrine Disorders
| Genmutation BRAF, NRAS, KIT, GNAQ, GNA11 Known/Determined
* Infectious Diseases
|-
* Malignancy
| Other Detected Genmutations
* Autoimmune Disorders
|}
* Organ Transplantation
* Other Comorbidities
 
 
'''Medications Usage'''
* Analgesics: Start and Stop Dates, Reason for Use
* Antibiotics: Start and Stop Dates, Reason for Use
* Antiviral Agents: Start and Stop Dates, Reason for Use
* Anticoagulants and Thrombolytics: Start and Stop Dates, Reason for Use
* Anticonvulsants: Start and Stop Dates, Reason for Use
* Antiemetics: Start and Stop Dates, Reason for Use
* Anti-inflammatory Drugs: Start and Stop Dates, Reason for Use
* Corticosteroids: Start and Stop Dates, Reason for Use
* Imuran (Azathioprine): Start and Stop Dates, Reason for Use
* Interferon: Start and Stop Dates, Reason for Use
 
 
'''Metastases and Staging'''
* Metastases Staging?
* Tumor Stage Before (Neo)adjuvant Treatment
* Imaging: CT Thorax and/or Abdomen, PET-CT, MRI or CT of the Brain
* Lab Tests: S100, LDH Levels
* Locations of Current Tumor Presentation Metastases Confirmed?
* In-transit Metastases and/or Satellitosis
* Recurrent Primary Melanoma
 
 
'''Histology and Genetics'''
* Histology of Primary Tumor Examined
* Revision Histology of Primary Tumor
* Histology and/or Cytology of Current Tumor Presentation Available
* Genmutation BRAF, NRAS, KIT, GNAQ, GNA11 Known/Determined
* Other Detected Genmutations

Revision as of 15:43, 26 May 2024

Go back to Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands) page.

This is a summary of the variables available in the database. You can download the complete data dictionary. Click here to learn more.

Table 1: Basic Patient Information.

Variables
Healthcare Facility
Unique Patient Number
Date of Birth
Gender
Date of Death (if applicable)

Table 2: Melanoma Center Details.

Variables
Hospital Patient Number
Date of First Disease Presentation Diagnosis of Melanoma
Patient Type
Location of Primary Tumor
Pathology (PA) Result Known?
PA Number (TJJ-CCCCCC)
PA Laboratory

Table 3: Tumor Characteristics and Diagnosis.

Variables
Type of Eye Melanoma
Type of Melanoma
Breslow Thickness in Millimeters (unknown = 999)
Ulceration
Satellite / In-transit Metastasis
Sentinel Node Procedure Performed at Primary Diagnosis?
Capsule Rupture Occurrence?
Sentinel Node Diameter
Primary Melanoma Regression?
Lymph Node Metastases (macroscopic)
Distant Metastases
Locations of Current Tumor Presentation

Table 4: Comorbidities.

Variables
Cardiac
Vascular
Diabetes
Pulmonary
Neurological/Psychiatric
Gastrointestinal
Urogenital
Thrombotic
Musculoskeletal
Endocrine Disorders
Infectious Diseases
Malignancy
Autoimmune Disorders
Organ Transplantation
Other Comorbidities

Table 5: Medications Usage.

Variables
Analgesics: Start and Stop Dates, Reason for Use
Antibiotics: Start and Stop Dates, Reason for Use
Antiviral Agents: Start and Stop Dates, Reason for Use
Anticoagulants and Thrombolytics: Start and Stop Dates, Reason for Use
Anticonvulsants: Start and Stop Dates, Reason for Use
Antiemetics: Start and Stop Dates, Reason for Use
Anti-inflammatory Drugs: Start and Stop Dates, Reason for Use
Corticosteroids: Start and Stop Dates, Reason for Use
Imuran (Azathioprine): Start and Stop Dates, Reason for Use
Interferon: Start and Stop Dates, Reason for Use

Table 6: Metastases and Staging.

Variables
Metastases Staging?
Tumor Stage Before (Neo)adjuvant Treatment
Imaging: CT Thorax and/or Abdomen, PET-CT, MRI or CT of the Brain
Lab Tests: S100, LDH Levels
Locations of Current Tumor Presentation Metastases Confirmed?
In-transit Metastases and/or Satellitosis
Recurrent Primary Melanoma

Table 7: Histology and Genetics.

Variables
Histology of Primary Tumor Examined
Revision Histology of Primary Tumor
Histology and/or Cytology of Current Tumor Presentation Available
Genmutation BRAF, NRAS, KIT, GNAQ, GNA11 Known/Determined
Other Detected Genmutations